Skip to main navigation Skip to search Skip to main content

Ipilimumab in adjuvant setting prolongs survival in stage III melanoma

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)1
Number of pages1
JournalMolecular and Cellular Pharmacology
Volume8
Issue number1
DOIs
StatePublished - 2016

Fingerprint

Dive into the research topics of 'Ipilimumab in adjuvant setting prolongs survival in stage III melanoma'. Together they form a unique fingerprint.

Cite this